FDA Commissioner Dr. Marty Makary on streamlining approvals for biosimilar generic drugs

FDA Commissioner Dr. Marty Makary joins 'Squawk Box' to discuss plans to speed up the approval of biosimilar generic drugs in a plan to help lower health care costs, pushback from the pharmaceuticals industry, and more.